Skip to main content
Home

Language & Country Selector for Desktop

language-selector-globe Malaysia | en

Choose Location

  • International
  • Americas
  • Europe
  • Middle East & Africa
  • Asia Pacific
  • Global | en
  • Sandoz | en
  • Novartis Foundation | en
  • Argentina | es
  • Brazil | pt
  • Canada | en
  • Canada | fr
  • Central America | es
  • Colombia | es
  • Latin America | es
  • Mexico | es
  • United States | en
  • Venezuela | es
  • Austria | de
  • Belgium | fr
  • Belgium | nl
  • Bulgaria | bg
  • Czech Republic | cs
  • Czech Republic | en
  • Denmark | da
  • Estonia | et
  • Finland | fi
  • France | fr
  • Germany | de
  • Greece | el
  • Hungary | hu
  • Ireland | en
  • Italy | it
  • Latvia | lv
  • Lithuania | lt
  • Netherlands | nl
  • Norway | no
  • Poland | pl
  • Portugal | pt
  • Romania | ro
  • Russia | ru
  • Serbia | sr
  • Slovakia | sk
  • Spain | es
  • Sweden | sv
  • Switzerland | de
  • Switzerland | fr
  • United Kingdom | en
  • Egypt | en
  • South Africa | en
  • Turkey | tr
  • Australia | en
  • Bangladesh | en
  • Hong Kong S.A.R. | zh
  • India | en
  • Indonesia | en
  • Japan | ja
  • Korea | ko
  • Mainland China | zh
  • Malaysia | en
  • Pakistan | en
  • Philippines | en
  • Singapore | en
  • Taiwan | zh

Language & Country Selector for Mobile

language-selector-globe my

Choose Location

International Americas Europe Middle East & Africa Asia Pacific
  • Argentina | es
  • Australia | en
  • Austria | de
  • Bangladesh | en
  • Belgium | fr
  • Belgium | nl
  • Brazil | pt
  • Bulgaria | bg
  • Canada | en
  • Canada | fr
  • Central America | es
  • Colombia | es
  • Czech Republic | cs
  • Czech Republic | en
  • Denmark | da
  • Egypt | en
  • Estonia | et
  • Finland | fi
  • France | fr
  • Germany | de
  • Global | en
  • Greece | el
  • Hong Kong S.A.R. | zh
  • Hungary | hu
  • India | en
  • Indonesia | en
  • Ireland | en
  • Italy | it
  • Japan | ja
  • Korea | ko
  • Latin America | es
  • Latvia | lv
  • Lithuania | lt
  • Mainland China | zh
  • Malaysia | en
  • Mexico | es
  • Netherlands | nl
  • Norway | no
  • Sandoz | en
  • Novartis Foundation | en
  • Pakistan | en
  • Philippines | en
  • Poland | pl
  • Portugal | pt
  • Romania | ro
  • Russia | ru
  • Serbia | sr
  • Singapore | en
  • Slovakia | sk
  • South Africa | en
  • Spain | es
  • Sweden | sv
  • Switzerland | de
  • Switzerland | fr
  • Taiwan | zh
  • Turkey | tr
  • United Kingdom | en
  • United States | en
  • Venezuela | es
    • About
      • Novartis in Malaysia
      • Strategy
      • Diversity and Inclusion
      • People and Culture
      • Products
      • Country Leadership Team
      • Diversity and Inclusion
      • Our Business
      • Novartis Mission & Vision
      About
    • Patients and Caregivers
      • Novartis Commitment to Patients and Caregivers
      • Diseases
      • Adverse Event Reporting
      • Our Process
      Patients and Caregivers
    • Healthcare Professionals
      • Healthcare professional country resource
      • Novartis Pipeline
      • Adverse Event Reporting
      • Novartis Clinical Trials
      • Therapeutic Areas
      Healthcare Professionals
    • ESG
      • Ethical Behavior
        • Code of Ethics
        • SpeakUp
      • Ethics, Risk and Compliance
      • Access
      • Environmental Sustainability
      • Global Health
      ESG
    • News
      • Stories
      • News Archive
      • Contacts
      News
    • Careers
      • Career Search
      • Meet the teams
      • Personal Growth
      • Early Talent
      • How We Work
      • Well-being
      • Awards and Recognition
      Careers
    • Coronavirus
    • Contact
    Home

Stories

Story Navigation
  • All Topics
  • Hope
  • Education and Awareness
icon
  • May 12, 2022
    Sneak Peek of Novartis Malaysia's New Office

    As we transition to the endemic phase of Covid-19, we have taken the lead in re-imagining the future of how we work to do much for our patients and the 32 million Malaysians we serve.

    Here’s a sneak peek of how we curated an office to lead in the hybrid world of today which places flexibility at its core and unleashes the power of our people to live up to our Inspired, Curious and Unbossed culture.

    #LEED #WELL #futurewaysofworking #hybrid

  • Education and Awareness
    Jan 31, 2022
    Improved Survival for Advanced Breast Cancer Patients
    Education and Awareness
  • Hope
    Jan 31, 2022
    #BePsoPositive in support of Psoriasis Patients
    Hope
  • Hope
    Jan 31, 2022
    Do you realize how difficult it is to live with Psoriasis?
    Hope
  • Education and Awareness
    Jan 31, 2022
    "Keep It Pumping"

    Don’t fail your heart, or it may fail you

    Education and Awareness
  • Hope
    Jan 31, 2022
    Let it Be Clear...
    Hope
  • Education and Awareness
    Jan 31, 2022
    Not Alone with Psoriasis
    Education and Awareness
  • Education and Awareness
    Jan 31, 2022
    Turning Perceptions Inside Out
    Education and Awareness
  • Education and Awareness
    Jan 31, 2022
    Do you know what is Ankylosing Spondylitis? We asked Malaysians this one simple question, see how we fare.
    Education and Awareness
  • Hope
    Jan 31, 2022
    A personal quest to prevent blindness

    When Parisa Zamiri was a young girl in Iran, it made her sad to see how her blind grandmother struggled with day-to-day tasks.

    Hope

Novartis Malaysia

Navigate Novartis
  • Patients & Caregivers
  • Healthcare Professionals
  • ESG
  • News
  • Careers
Media Center
  • Press Releases and Stories
Our Portfolio
  • Novartis Clinical Pipeline
  • Novartis Product Portfolio
Footer Bottom
© 2022 Novartis AG
  • Privacy Policy
  • Terms of Use
  • Cookie Settings
  • Site Map
  • Web Accessibility
Novartis Site Directory
This site is intended for an audience in Malaysia